Form 4 holding
Chief Scientific Officer, Director
ORAMED PHARMACEUTICALS INC.
- Security class
- Common Stock
- Shares / value
- 2,149,554
- Estimated value
- $10,038,417
- Report date
- 12 Nov 2026
- Price
- $4.67
- Ownership
- Direct
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|